Optiscan Imaging Ltd
Research Optiscan Imaging Ltd (OIL) on Bullrun: market cap AUD 177.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOIL
- ExchangeAU
- CountryAustralia
- SectorTechnology
- IndustryScientific & Technical Instruments
- CurrencyAUD
- Market capAUD 177.51M
- Financial periodFY2025
- RevenueAUD 951.95K
- Revenue growth-17.6%
- Net income-AUD 6.31M
- Free cash flow-AUD 6.31M
- Gross margin50.4%
Valuation Snapshot
latest market cap is AUD 177.51M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 951.95K | -AUD 6.31M | -AUD 6.31M | 50.4% | -0.01 | AUD 4.55M | AUD 1.48M | AUD 7.71M |
| FY2024 | AUD 1.16M | -AUD 6.06M | -AUD 5.83M | 54.5% | -0.01 | AUD 6.10M | AUD 220.91K | AUD 13.87M |
| FY2023 | AUD 1.68M | -AUD 4.35M | -AUD 3.28M | 67.1% | -0.01 | AUD 875.37K | AUD 412.29K | AUD 3.04M |
| FY2022 | AUD 1.01M | -AUD 4.23M | -AUD 3.96M | 100.0% | -0.01 | AUD 4.53M | AUD 548.67K | AUD 6.59M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | AUD 177.51M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions;
Related stock research
Other Technology stocks
Frequently asked questions
What is Optiscan Imaging Ltd's market cap?
Optiscan Imaging Ltd's market capitalization is AUD 177.51M.
What does Optiscan Imaging Ltd do?
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research.